GlySens Incorporated
PrivateLast Round
VC Round
Jun 12, 2020
Total Funding Raised
$32.1M
Company Overview
GlySens Incorporated is a biotechnology company that develops implantable continuous glucose monitoring systems for diabetes management.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Health IoT, Sensors, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GlySens Incorporated Comparables
Compare GlySens Incorporated with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GlucoTrack Inc | 82% | |
| Senseonics Holdings, Inc. | 81% | |
| Indigo Diabetes N.V. | 77% |
GlySens Incorporated Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 12, 2020 | ||||
| Series D | Jan 5, 2016 | ||||
| Series C | Jan 5, 2015 | ||||
| VC Round | Sep 14, 2012 | ||||
| Grant | Jan 1, 2005 |
GlySens Incorporated Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| McNair Interests | VC Round |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Windham Capital Partners | Series D |
| Fayez Sarofim & Co. | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2012
Led by West Health, an Impact Investor.
GlySens Incorporated Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GlySens Incorporated's valuation, stock price, and market status.
Is GlySens Incorporated a public or private company?
GlySens Incorporated is a private company.
What is the current stock price of GlySens Incorporated?
GlySens Incorporated is a private company with no public stock price. No recent secondary market data is available.
How much is GlySens Incorporated worth (valuation)?
Valuation information for GlySens Incorporated is not publicly available.
Can I buy GlySens Incorporated stock?
GlySens Incorporated shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GlySens Incorporated's last funding round?
GlySens Incorporated's most recent funding round was VC Round on June 12, 2020.
Who are the main investors in GlySens Incorporated?
Key investors in GlySens Incorporated include McNair Interests, National Institute of Diabetes and Digestive and Kidney Diseases, Fayez Sarofim & Co..
Will GlySens Incorporated IPO soon?
No public IPO plans have been announced for GlySens Incorporated.
How can I track GlySens Incorporated secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GlySens Incorporated's secondary market activity and sign up for updates.